Evaluation of the Impact of Self-Efficacy-Based Training on Depression, Self-Care Behaviors, and Quality of Life in Patients with Irritable Bowel Syndrome

Self Efficacy ◽

Self Care ◽

Control Group ◽

Life Questionnaire ◽

Irritable Bowel ◽

Background and Objectives: Irritable bowel syndrome is the most common diagnosis among patients with gastrointestinal diseases and can adversely affect their quality of life. In this regard, the present study aimed to evaluate the effectiveness of self-efficacy-based training on depression, self-care behaviors, and the quality of life of patients with irritable bowel syndrome. Materials and Methods: This applied quasi-intervention study was conducted based on a pretest-posttest design with a control group and follow-up. The statistical population included all patients with irritable bowel syndrome who referred to Khorshid Hospital in Isfahan, Iran from September to November 2019. The samples were selected using the convenience sampling method. In total, 30 patients with irritable bowel syndrome were included in the study and randomly divided into two groups of intervention and control. The data were collected using Beck depression inventory, self-care questionnaire, and quality of life questionnaire. The intervention group received four sessions of self-efficacy training (one session per week for 90 min), while the control group did not receive any training. Two months later, the follow-up period was completed. The collected data were analyzed using repeated measures of analysis of variance in SPSS software (version 22). Results: The results showed that self-efficacy training was effective in decreasing depression (P<0.0001, F=35.39) and increasing quality of life (P<0.0001, F=120.30) and self-care behaviors (P<0.0001, F=70.50) in patients with irritable bowel syndrome. Conclusion: It can be concluded that training based on self-efficacy theory can effectively reduce depression and increase self-care behaviors and quality of life in patients with irritable bowel syndrome.

Comparison of Mindfulness-Based Cognitive Therapy and Neurofeedback on Quality of Life of Patients With Irritable Bowel Syndrome

Caspian Journal of Health Research ◽

10.32598/cjhr.6.4.379.1 ◽

2021 ◽

Vol 6 (4) ◽

pp. 129-136

Author(s):

Noura Khosh Chin Gol ◽

◽

Bahman Akbari ◽

Leila Moghtader ◽

Iraj Shakerinia ◽

...

Keyword(s):

Quality Of Life ◽

Cognitive Therapy ◽

General Health ◽

Control Group ◽

Total Quality ◽

Post Test ◽

Irritable Bowel

Background: Irritable Bowel Syndrome (IBS) is one of the most common gastrointestinal disorders and is usually associated with abdominal pain. This study aimed to compare the effectiveness of mindfulness and neurofeedback on quality of life in patients with irritable bowel syndrome. Materials & Methods: The present study was a pretest-posttest control group design with a two-month follow-up. The study population included all women with irritable bowel syndrome referred to gastroenterology centers and clinics of Qazvin city in 2019. Patients were selected by convenience sampling and randomly assigned into two experimental and one control groups (n=45). The experimental groups underwent Mindfulness-Based Cognitive Therapy (MBCT) and Neurofeedback (NFB). The Rome-III diagnostic criteria form and the WHOQOLBREF were administered. Data were analyzed using repeated measure analysis of variance. Results: There was significant difference between NFB and control group for total quality of life and all its components. The mean between-group difference (MD) of total quality of life score in NFB compared to control group was 21.2±2.58 in post-test and 15.4±2.35 in follow-up (P<0.05). MBCT group was significantly different with the control group in component of general health both in post-test (MD= 0.93±0.53) and follow-up (MD=0.73±0.53), (P<0.05). Conclusion: NFB therapy considerably improved the quality of life of patients with IBS that was remained after two months of follow-up, while MBCT was only effective on improvement of general health in comparison with the control group.

Defense Mechanisms in Patients with Irritable Bowel Syndrome and Their Relationship with Symptom Severity and Quality of Life

Middle East Journal of Digestive Diseases ◽

10.15171/mejdd.2019.143 ◽

2019 ◽

Vol 11 (3) ◽

pp. 158-165

Author(s):

Fahimeh Saeed ◽

Mansour Salehi ◽

Kaveh Alavi ◽

Hossein Ajdarkosh ◽

Fatemeh Kashaninasab ◽

...

Keyword(s):

Quality Of Life ◽

Defense Mechanisms ◽

Control Group ◽

Life Questionnaire ◽

Acting Out ◽

The Mean ◽

Irritable Bowel ◽

Passive Aggression

BACKGROUND Despite the fact that there is theoretical evidence about the association between unconscious defense mechanisms and irritable bowel syndrome (IBS), experimental evidence in this regard is limited. The aim of the present study was to compare the defense mechanisms used by the patients with IBS and a control group, and to investigate the relationship between these mechanisms with the severity of the disease and patients’ quality of life. METHODS Fourty-five patients with IBS (mean age of 37.1 years; 14 males) and 45 controls (mean age of 38.0 years; 13 males) were evaluated. IBS diagnosis was determined based on Rome III criteria and the predominant pattern of the disease was determined based on the patient’s history (13 diarrheapredominant, 16 constipation-predominant, and 16 alternating IBS). Defense Style Questionnaire-40, IBS Severity Scale, and IBS-Quality of Life questionnaire were used. RESULTS The mean scores of projection, acting-out, somatization, autistic fantasy, passive-aggression, and reaction formation in the IBS group were significantly higher than the control group and the mean scores of humor and anticipation mechanisms were higher in the control group. There was no significant correlation between the score of defense mechanisms and the severity of IBS and the patients’ quality of life. CONCLUSION The severity of immature defenses in the IBS group was significantly higher, whereas the severity of mature defenses was higher in the control group. These defenses were not correlated with the severity of IBS. Considering the limited sample size, these relationships need to be more investigated.

The impact of irritable bowel syndrome on health-related quality of life in women with polycystic ovary syndrome

10.21203/rs.2.17261/v1 ◽

2019 ◽

Author(s):

Seyed Abdolvahab Taghavi ◽

Zatollah Asemi ◽

Fatemeh Bazarganipour ◽

Helen Allan ◽

Zahra Khashavi ◽

...

Keyword(s):

Quality Of Life ◽

Polycystic Ovary Syndrome ◽

Polycystic Ovary ◽

Control Group ◽

Ovary Syndrome ◽

Food Avoidance ◽

Irritable Bowel ◽

Abstract The objectives of this study were to compare the prevalence and quality of life (QOL) of irritable bowel syndrome (IBS) in women with polycystic ovary syndrome (PCOS) compared with healthy women.Methods This was a case-control study of 201 women recruited at an infertility clinic in Iran. The control group were healthy women (n=100) and the comparison group, women with PCOS (n=101). Data were collected by clinical Rome III criteria to determine the IBS, Bristol scale for stool consistency and IBS QOL.Results The reporting of IBS symptoms was higher in PCOS (20.7%) than control group (11%) (P=0.05). Predictive factors of IBS included having diagnosed PCOS (OR: 1.61; CI: 0.71–2.11) and an increase of LH/FSH (OR: 1.09; 0.95 CI: (0.83-1.45). The IBS QOL score in the IBS+PCOS group was lower than other groups (IBS+ non PCOS, non IBS+PCOS, non IBS+ non PCOS; scores in food avoidance and worries about health domains were significant (P<0.01). Conclusions: We conclude that having PCOS and an increased level of LH/FSH tends to cause IBS symptoms. IBS+PCOS women experience significant impaired quality of life scores particularly in relation to worries about health and food avoidance. These results offer further insights into IBS in PCOS women and their functional status and wellbeing.

Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms

Scientific Reports ◽

10.1038/s41598-021-87158-2 ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

L. Quénéhervé ◽

D. Drui ◽

J. Blin ◽

M. Péré ◽

E. Coron ◽

...

Keyword(s):

Quality Of Life ◽

Adrenal Insufficiency ◽

Gastrointestinal Symptoms ◽

Control Group ◽

Non Profit ◽

Acute Adrenal Insufficiency ◽

Irritable Bowel ◽

Rome Iv

AbstractGastrointestinal symptoms are frequent in acute adrenal insufficiency. Although digestive symptoms can significantly reduce quality of life, they are rarely described in patients with treated chronic adrenal insufficiency (CAI). We aimed to characterize digestive symptoms in CAI patients. We used the section pertaining functional bowel disorders of the Rome IV questionnaire. A questionnaire was published on the website of the non-profit patient association “Adrenals” (NPPA of CAI patients) for five months. Information on demographics, characteristics of adrenal insufficiency, digestive symptoms and quality of life was collected. The relatives of CAI patients served as a control group. We analyzed responses of 33 control subjects and 119 patients (68 primary adrenal insufficiency (PAI), 30 secondary adrenal insufficiency (SAI) and 21 congenital adrenal hyperplasia (CAH)). Abdominal pain at least once a week over the past 3 months was reported by 40%, 47% and 33% of patients with PAI, SAI and CAH respectively versus 15% for the controls (p = 0.01). Symptoms were consistent with the Rome IV criteria for irritable bowel syndrome in 27%, 33% and 33% of patients respectively versus 6% for the controls (p < 0.0001). Quality of life was described as poor or very poor in 35%, 57% and 24% of patients respectively versus 5% for the controls (p < 0.0001). In conclusion, digestive symptoms are frequent and incapacitating in CAI patients and similar to symptoms of irritable bowel syndrome in 30% of CAI patients. Assessment and management of digestive symptoms should be considered a priority for physicians treating patients with CAI.

The impact of Irritable Bowel Syndrome on health-related quality of life: a Singapore perspective

BMC Gastroenterology ◽

10.1186/1471-230x-12-104 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 21

Author(s):

Yu Tien Wang ◽

Hwee Yong Lim ◽

David Tai ◽

Thinesh L Krishnamoorthy ◽

Tira Tan ◽

...

Keyword(s):

Quality Of Life ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Irritable Bowel ◽

Item-Level Assessment of the Irritable Bowel Syndrome Quality of Life Questionnaire in Patients With Diarrheal Irritable Bowel Syndrome

Clinical Therapeutics ◽

10.1016/j.clinthera.2014.04.009 ◽

2014 ◽

Vol 36 (5) ◽

pp. 663-679 ◽

Cited By ~ 8

Author(s):

David A. Andrae ◽

Paul S. Covington ◽

Donald L. Patrick

Keyword(s):

Quality Of Life ◽

Life Questionnaire ◽

Quality Of Life Questionnaire ◽

Item Level ◽

Irritable Bowel

Evaluation of the quality of life of patients with oral cancer in Brazil

Brazilian Oral Research ◽

10.1590/s1806-83242006000400002 ◽

2006 ◽

Vol 20 (4) ◽

pp. 290-296 ◽

Cited By ~ 15

Author(s):

Fabiana Paula de Andrade ◽

José Leopoldo Ferreira Antunes ◽

Marcelo Doria Durazzo

Keyword(s):

Quality Of Life ◽

Oral Cancer ◽

Clinical Characteristics ◽

Posterior Part ◽

Self Report ◽

Life Questionnaire ◽

Longitudinal Assessment ◽

This study performed a field trial of a Portuguese version of the University of Washington quality of life questionnaire (UW-QOL, 3rd version), aiming at appraising its ability to identify different patterns of health-related quality of life of patients with oral cancer in Brazil. Patients (N = 100) were interviewed as they were undergoing treatment for oral squamous cell carcinoma at a large Brazilian hospital ("Hospital das Clínicas", School of Medicine, University of São Paulo). The results were compared based on categories of socio-demographic and clinical characteristics of the patients. At a one-year follow-up, 20 patients had died, and 24 were considered dropouts. The remaining patients accounted for the longitudinal assessment of modifications in the self report of quality of life. Patients with larger tumours and neoplasms in the posterior part of the mouth presented significantly (p < 0.05) poorer indications of quality of life. Chewing was the poorest rated domain (35.0/100.0), and presented the highest proportion of complaints both at the baseline and at the follow-up assessments. The questionnaire allowed the identification of important contrasts (while comparing clinical characteristics) and similarities (while comparing socio-demographic status) among subsets of respondents, and it can contribute to reduce the impact of treatments and improve subsequent patient management.

A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up

Nutrients ◽

10.3390/nu12082360 ◽

2020 ◽

Vol 12 (8) ◽

pp. 2360 ◽

Cited By ~ 2

Author(s):

Massimo Bellini ◽

Sara Tonarelli ◽

Federico Barracca ◽

Riccardo Morganti ◽

Andrea Pancetti ◽

...

Keyword(s):

Quality Of Life ◽

Nutritional Adequacy ◽

Related Quality ◽

Short And Long Term ◽

Irritable Bowel ◽

Fodmap Diet

A low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet (LFD) is a possible therapy for irritable bowel syndrome (IBS). This study investigates the short- and long-term efficacy and nutritional adequacy of an LFD and the patients’ long-term acceptability. Patients’ adherence and ability to perceive the “trigger” foods were also evaluated. Seventy-three IBS patients were given an LFD (T0) and after 2 months (T1), 68 started the reintroduction phase. At the end of this period (T2), 59 were advised to go on an Adapted Low-FODMAP Diet (AdLFD) and 41 were evaluated again after a 6–24 month follow-up (T3). At each time, questionnaires and Biolectrical Impedance Vector Analysis (BIVA) were performed. The LFD was effective in controlling digestive symptoms both in the short- and long-term, and in improving quality of life, anxiety and depression, even if some problems regarding acceptability were reported and adherence decreased in the long term. The LFD improved the food-related quality of life without affecting nutritional adequacy. When data collected at T0 were compared with those collected at T2, the perception of trigger foods was quite different. Even if some problems of acceptability and adherence are reported, an LFD is nutritionally adequate and effective in improving IBS symptoms also in the long term.